Bios

Founders

Yadin Shemmer

Executive Director

Prior to joining Endeavour Health, Yadin was a director at Grosvenor Park Investment Partners, a mezzanine debt focused fund backed by a $30 billion hedge fund based in New York. Prior to joining Grosvenor Park, Yadin worked as a financial analyst at Broadview International, an investment bank specializing in mergers and acquisitions in the IT sectors. Yadin holds an MBA from the London Business School and a B.A. from the University of Pennsylvania.

Dr. Jonathan Weiss

Executive Director

In addition to his role with Endeavour Health, Jonathan is co-founder and director of Bridgeview Partners, a firm that establishes and/or funds businesses in the health, education, and retail sectors. Previously, he was co-founder, CEO and director of several companies including Nations Healthcare, one of the largest diagnostic and surgery centre companies contracted in the United Kingdom to build, staff and manage centres which diagnose and treat 300,000 patients annually. Jonathan is a medical doctor and has also earned law, business, and economics/policy qualifications.

He is a graduate of the University of Chicago Pritzker School of Medicine and Booth School of Business, having completed both an MD and an MBA under Chicago's dual degree program. He was educated as a lawyer, receiving his BA degree from Oxford University, and additionally holds an MSc in Health Economics and Policy from Stanford University and a BA in Government from Harvard University.

In addition to his entrepreneurial pursuits and non-executive roles for UK-based companies, Jonathan often acts as a director or consultant to several US companies, including Fortune 100 insurers and medical management firms; serves as an elected director to the Board of the Oxford University Society; is a non-executive director on IDTM’s board, a Swedish company with international operations in the sports drug testing industry; is a Co-opted Trustee of the RMBI elderly care homes portfolio; and serves as a director leading on company strategy and mergers and acquisitions on behalf of several groups with over $3 billion in assets under management.